Overview
Lipase is an enzyme responsible for the breakdown of dietary fats into smaller molecules for absorption in the intestines. It is mainly produced by the pancreas, with additional contributions from the mouth and stomach. Serum lipase estimation is widely used as a marker of pancreatic function, as increased levels are commonly associated with pancreatic disorders. It may also be detected in urine, particularly in cases of renal impairment, where elevated levels reflect reduced clearance rather than primary pancreatic pathology.
Symptoms
Clinical symptoms prompting lipase testing are often related to pancreatic involvement. These include pain in the upper abdomen that may radiate to the back, nausea, vomiting, diarrhea, abdominal tenderness or swelling, fever, and tachycardia. Such symptoms are especially suggestive when acute pancreatitis is suspected, as its levels rise early and remain elevated for a prolonged period compared to other pancreatic enzymes.
Causes
Raised lipase levels are most commonly caused by pancreatic conditions such as acute pancreatitis, where levels increase within a few hours of onset and may remain elevated for up to two weeks. Chronic pancreatitis, pancreatic cancer, and pancreatic trauma can also result in elevated values. Non-pancreatic causes include hepatobiliary and gastrointestinal disorders such as cholecystitis, bowel obstruction, peptic ulcer disease, inflammatory bowel disease, and celiac disease.
Renal disorders may lead to falsely elevated lipase due to reduced clearance. Metabolic conditions like diabetes mellitus and diabetic ketoacidosis, systemic infections, abdominal trauma, critical illness, and certain medications can also contribute to increased lipase levels. Low lipase levels may be seen in conditions causing permanent pancreatic damage, such as chronic pancreatitis, cystic fibrosis, advanced pancreatic cancer, certain drug effects, or rare genetic enzyme deficiencies.
Risk Factors
Risk factors for abnormal lipase levels include gallstone disease, hypertriglyceridemia, obesity, renal impairment, metabolic disorders, and the use of medications that influence pancreatic enzymes. Improper sample collection, delayed processing, or the use of unsuitable collection tubes can affect test accuracy. Certain drugs, such as oral contraceptives, cholinergic medicines, opioids, diuretics, and nonsteroidal anti-inflammatory drugs, may interfere with results and should be considered during interpretation.
Prevention
Accurate interpretation of lipase levels depends on appropriate patient preparation and sample handling. Patients are advised to avoid food intake for at least eight hours before sample collection and to temporarily discontinue medications that may alter lipase levels when clinically feasible. Blood samples should be collected in suitable tubes and serum or plasma separated promptly. Urine samples should be collected in sterile containers when indicated. Timely transportation and proper storage of samples help ensure reliable results. Correct clinical correlation allows early diagnosis and effective management of pancreatic and related disorders.
